680 related articles for article (PubMed ID: 26815287)
1. Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
Gupta S; Tatouli IP; Rosen LB; Hasni S; Alevizos I; Manna ZG; Rivera J; Jiang C; Siegel RM; Holland SM; Moutsopoulos HM; Browne SK
Arthritis Rheumatol; 2016 Jul; 68(7):1677-87. PubMed ID: 26815287
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.
Spadaro A; Rinaldi T; Riccieri V; Taccari E; Valesini G
Clin Exp Rheumatol; 2002; 20(2):213-6. PubMed ID: 12051401
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
4. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
[TBL] [Abstract][Full Text] [Related]
5. A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases.
Simon Q; Grasseau A; Boudigou M; Le Pottier L; Bettachioli E; Cornec D; Rouvière B; Jamin C; Le Lann L; ; ; Borghi MO; Aguilar-Quesada R; Renaudineau Y; Alarcón-Riquelme ME; Pers JO; Hillion S
Arthritis Rheumatol; 2021 Aug; 73(8):1550-1561. PubMed ID: 33605069
[TBL] [Abstract][Full Text] [Related]
6. Brief Report: Anti-Calponin 3 Autoantibodies: A Newly Identified Specificity in Patients With Sjögren's Syndrome.
Birnbaum J; Hoke A; Lalji A; Calabresi P; Bhargava P; Casciola-Rosen L
Arthritis Rheumatol; 2018 Oct; 70(10):1610-1616. PubMed ID: 29749720
[TBL] [Abstract][Full Text] [Related]
7. Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.
Umeda N; Matsumoto I; Ito I; Kawasaki A; Tanaka Y; Inoue A; Tsuboi H; Suzuki T; Hayashi T; Ito S; Tsuchiya N; Sumida T
Clin Exp Immunol; 2013 Apr; 172(1):44-53. PubMed ID: 23480184
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to alpha-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay.
Nordmark G; Rorsman F; Rönnblom L; Cajander S; Taussig MJ; Kämpe O; Winqvist O
Clin Exp Rheumatol; 2003; 21(1):49-56. PubMed ID: 12673889
[TBL] [Abstract][Full Text] [Related]
9. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
10. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
[TBL] [Abstract][Full Text] [Related]
11. Cytokine Profiles in Autoantibody Defined Subgroups of Systemic Lupus Erythematosus.
Torell F; Eketjäll S; Idborg H; Jakobsson PJ; Gunnarsson I; Svenungsson E; Trygg J
J Proteome Res; 2019 Mar; 18(3):1208-1217. PubMed ID: 30742448
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
[TBL] [Abstract][Full Text] [Related]
14. Methods for type I interferon detection and their relevance for clinical utility and improved understanding of rheumatic diseases.
Lamot L; Niemietz I; Brown KL
Clin Exp Rheumatol; 2019; 37(6):1077-1083. PubMed ID: 30943143
[TBL] [Abstract][Full Text] [Related]
15. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
[TBL] [Abstract][Full Text] [Related]
16. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
Wang Y; Xie X; Zhang C; Su M; Gao S; Wang J; Lu C; Lin Q; Lin J; Matucci-Cerinic M; Furst DE; Zhang G
Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
Blokland SLM; van den Hoogen LL; Leijten EFA; Hartgring SAY; Fritsch R; Kruize AA; van Roon JAG; Radstake TRDJ
Rheumatology (Oxford); 2019 Oct; 58(10):1740-1745. PubMed ID: 31220315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
